finasteride

Italy

Drugs containing this active substance

  • ASTERID

    The drug is used for the treatment and control of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate, to improve urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: EPIFARMA S.R.L

  • It is used by men to treat early stages of hair loss (androgenetic alopecia). It is indicated for men between 18 and 41 years of age with mild to moderate hair loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: DIFA COOPER S.P.A.

  • It is used for the treatment of mild to moderate male hair loss (androgenetic alopecia). It helps to increase hair growth on the scalp and prevent further hair loss.

    Form: spray, cutaneous solution

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: DIFA COOPER S.P.A.

  • This medicine is used to treat benign prostatic hyperplasia (BPH), which is a benign enlargement of the prostate common in men over 50 that can cause difficulty urinating, a weak flow, or the frequent need to urinate.

    Form: tablets, film-coated

    Active substance Dosage
    doxazosin mesylate -
    finasteride -

    ATC: G04CA

    Manufacturer: MYLAN S.P.A.

  • The drug is indicated for men between 18 and 41 years of age to treat early stages of androgenetic alopecia (hair loss), with the aim of stabilizing the process.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: PHARMACARE S.R.L.

  • It is used for the treatment of early stages of male pattern hair loss (androgenetic alopecia) in men aged between 18 and 41 years, with mild to moderate hair loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: GIULIANI SPA

  • It is used to treat benign prostatic hyperplasia (BPH), a common condition in men over 50 years of age in which the prostate enlarges, causing problems such as difficulty urinating, weak flow, or the frequent need to urinate.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -
    doxazosin mesylate -

    ATC: G04CA

    Manufacturer: PROGE MEDICA S.R.L.

  • This medicine is used for the treatment and control of benign prostatic hyperplasia (BPH), a condition characterized by the benign enlargement of the prostate. It helps to improve urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: ABC FARMACEUTICI S.P.A.

  • The 1 mg drug is indicated to prevent hair loss in the male pattern of baldness (androgenetic alopecia). The 5 mg drug is used for the treatment and control of benign prostatic enlargement (benign prostatic hyperplasia).

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • This medicine is used to reduce the size of the prostate in men when it is enlarged (benign prostatic hypertrophy not associated with tumors), improving urine flow and reducing symptoms and the risk of surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: LABORATORI ALTER S.R.L.

  • It is used for the treatment and management of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate. The medicine helps to improve urinary flow, reduce the risk of acute urinary retention, and the need for surgical interventions.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

  • It is used exclusively in men to treat male pattern hair loss (androgenetic alopecia) in individuals aged between 18 and 41 years, with mild to moderate baldness.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.

  • It is used for the treatment, in the early stages, of hair loss in men aged between 18 and 41 years (androgenetic alopecia).

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: LABORATOIRES BAILLEUL S.A.

  • This medicine is used to treat and control benign prostatic enlargement (benign prostatic hyperplasia) by acting to reduce the size of the gland and improving urinary flow.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: DOC GENERICI SRL

  • It is used for the treatment and management of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate. The drug helps to improve urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: IPSO PHARMA S.R.L.

  • This medicine is used to reduce the size of the prostate gland when it is enlarged (a condition called benign prostatic hyperplasia or BPH), helping to manage problems such as the need to urinate frequently, difficulty starting to urinate, or a weak urinary flow.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: MEDREG S.R.O.

  • It is used to treat male pattern hair loss (androgenetic alopecia) in men, helping to prevent further hair loss and reverse the hair loss process.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: MYLAN S.P.A.

  • This medicine is used for the treatment and control of benign prostatic hyperplasia (BPH), a condition characterized by the benign enlargement of the prostate. It works by improving urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: MYLAN S.P.A.

  • Depending on the prescribed dosage, this medication is used to treat male hair loss (androgenetic alopecia) to prevent further hair loss, or for the treatment and management of benign prostatic hyperplasia (enlarged prostate), improving urinary flow.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: TOWA PHARMACEUTICAL S.P.A.

  • It is used in men between 18 and 41 years of age for the treatment of early forms of male pattern hair loss (androgenetic alopecia).

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: PHARMACARE S.R.L.

  • This medicinal product is intended exclusively for men to treat and control benign prostatic hyperplasia, which is a non-aggressive enlargement of the prostate that can cause problems during urination.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: SANDOZ S.P.A.

  • The drug is used to treat benign prostatic hyperplasia (BPH), a condition in which the prostate enlarges, making it difficult for urine to pass. It works by reducing the size of the prostate and can decrease the risk of surgery or sudden inability to urinate.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: TECNIMEDE - SOCIEDADE TECNICO-MEDICINAL, SA

  • It is used for the treatment of male hair loss (androgenetic alopecia). It is indicated for men with mild to moderate hair loss, but not complete loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: TEVA ITALIA S.R.L.

  • It is used for the treatment and control of benign prostatic enlargement (benign prostatic hyperplasia - BPH). It works by reducing the size of the prostate gland, improving urinary flow, and reducing the risks of acute urinary retention and the need for surgical interventions.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: TEVA ITALIA S.R.L.

  • It is used to treat benign prostatic enlargement (Benign Prostatic Hyperplasia - BPH) and to reduce the risk of acute urinary retention or the need for surgery in patients with moderate or severe signs of this condition.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: ZENTIVA ITALIA S.R.L.

  • This medicine is used to treat and control benign prostatic enlargement in men. It works by reducing the size of the prostate gland, thereby improving urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: NEOPHARMED GENTILI S.P.A.

  • Finedor is used exclusively in men to shrink the prostate when it is enlarged (a condition known as benign prostatic hyperplasia or BPH).

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: LANOVA FARMACEUTICI S.R.L.

  • It is used to treat and control benign prostatic enlargement in men, helping to reduce the size of the gland, improve urinary flow, and related symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: NEOPHARMED GENTILI S.P.A.

  • It is used for the treatment of male pattern hair loss (androgenetic alopecia) in men aged 18 to 41 years, with mild to moderate hair loss.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: D11AX10

    Manufacturer: ORGANON ITALIA S.R.L.

  • It is used for the treatment and control of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate. It helps to improve urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: ORGANON ITALIA S.R.L.

  • It is used for the treatment and control of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate. The drug helps to improve urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: ALFASIGMA S.P.A.

  • It is used to treat and control benign prostatic enlargement (benign prostatic hyperplasia) in men, helping to reduce the size of the gland and improve urinary flow.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: S.F. GROUP S.R.L.

  • It is used to treat and control benign prostatic enlargement (benign prostatic hyperplasia - BPH). It works by reducing the size of the prostate gland, improving urinary flow and associated symptoms.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: GENETIC S.P.A.

  • This medicine is used to shrink an enlarged prostate gland in men (benign prostatic hyperplasia), helping to reduce urinary difficulties and the risk of surgery.

    Form: tablets, film-coated

    Active substance Dosage
    finasteride -

    ATC: G04CB01

    Manufacturer: PHARMACARE S.R.L.